Related Experiment Video
Updated: Mar 8, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Retrospective study of prognostic factors in pediatric invasive pneumococcal disease
Nan-Chang Chiu1,2,3, Hsin Chi1,2,3, Chun-Chih Peng1,2,3
1Department of Pediatrics, MacKay Children's Hospital, Taipei, Taiwan.
Insights
Invasive pneumococcal disease (IPD) in children is life-threatening. Leukopenia, thrombocytopenia, and high C-reactive protein levels are key predictors of mortality in pediatric IPD cases.
Area of Science:
- Pediatrics
- Infectious Diseases
- Microbiology
Background:
- Streptococcus pneumoniae is a major cause of pediatric pneumonia and bacteremia globally.
- Invasive pneumococcal disease (IPD) involves S. pneumoniae in normally sterile body sites.
Purpose of the Study:
- To investigate clinical features and laboratory findings of IPD in hospitalized children.
- To identify prognostic factors associated with mortality in pediatric IPD.
Main Methods:
- Retrospective chart review of pediatric patients diagnosed with pneumonia, arthritis, endocarditis, meningitis, or sepsis.
- Analysis of clinical data, laboratory results, and hospitalization courses for 50 confirmed cases of pneumococcal infection.
Main Results:
- The overall mortality rate for pediatric IPD was 10%.
- Leukopenia, thrombocytopenia, and elevated C-reactive protein (CRP) levels were significant predictors of mortality.
- Hemolytic uremic syndrome (HUS) occurred in 10% of patients; ECMO was used in 3 patients.
Conclusions:
- S. pneumoniae continues to pose a significant global health threat, with IPD being a life-threatening condition in children.
- Leukopenia, thrombocytopenia, and high CRP levels are critical indicators for mortality risk in pediatric IPD.
- Aggressive antibiotic treatment is recommended for patients presenting with these factors, pending further large-scale studies.
Abstract:
Streptococcus pneumoniae remains the leading causative pathogen in pediatric pneumonia and bacteremia throughout the world. The invasive pneumococcal disease (IPD) is known as isolation of S. pneumoniae from a normally sterile site (e.g., blood, cerebrospinal fluid, synovial fluid, pericardial fluid, pleural fluid, or peritoneal fluid). The aim of this study is to survey the clinical manifestations and laboratory results of IPD and identify the prognostic factors of mortality. From January 2001 to December 2006, a retrospective review of chart was performed in a teaching hospital in Taipei. The hospitalized pediatric patients with the diagnosis of pneumonia, arthritis, infectious endocarditis, meningitis or sepsis were recruited. Among them, 50 patients were pneumococcal infections proved by positive culture results or antigen tests. Clinical manifestations, laboratory data and hospitalization courses were analyzed. The median age was 3.5-year-old and there were 30 male patients (60%). Eight patients (16%) had underlying disease such as leukemia or congenital heart disease. Hemolytic uremic syndrome (HUS) was observed in ten patients and extracorporeal membrane oxygenation (ECMO) was performed in three patients. Leukocytosis, elevated C-reactive protein and AST level were noted in most of the patients. The overall mortality rate was 10%. We found that leukopenia, thrombocytopenia and high CRP level were significant predictors for mortality. In conclusion, S. pneumoniae remains an important health threat worldwide and IPD is life-threatening with high mortality rate. We found leukopenia, thrombocytopenia, and high CRP levels to be associated with mortality in pediatric IPD, and these factors are worthy of special attention at admission. Although we failed to identify a statistically significant prognostic factor in multivariate analysis due to relatively small sample size, we suggest an aggressive antibiotic treatment in patients with these factors at admission. Further large-scale studies are warranted.
More Related Videos
09:12Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
Published on: January 17, 2014
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....